Protection from inflammatory organ damage in a murine model of hemophagocytic lymphohistiocytosis using treatment with IL-18 binding protein

Frontiers in Immunology

Volumn 3, Issue AUG, 2012, Pages

  Chiossone, Laura ^a,b,h   Audonnet, Sandra ^a,b,c   Chetaille, Bruno ^d   Chasson, Lionel ^a,b   Farnarier, Catherine ^c   Berda Haddad, Yael ^c   Jordan, Stefan ^e   Koszinowski, Ulrich H ^e   Dalod, Marc ^a,b   Mazodier, Karin ^c   Novick, Daniela ^f   Dinarello, Charles A ^g   Vivier, Eric ^a,b,c   Kaplanski, Gilles ^c  

^a CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

^c HÔPITAL DE LA CONCEPTION   (France)

^d INSTITUT PAOLI CALMETTES   (France)

^e UNIVERSITY OF MUNICH   (Germany)

^f WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^g UNIVERSITY OF COLORADO   (United States)

^h G GASLINI INSTITUTE   (Italy)

Author keywords

Hemophagocytic lymphohistiocytosis; IL 18; IL 18 binding protein; Macrophage activation syndrome; Natural killer cells

Indexed keywords

EID: 84874208216     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2012.00239     Document Type: Article

References (50)

1. Badovinac, V. P., Hamilton, S. E., and Harty, J. T. (2003). Viral infection results in massive CD8+ T cell expansion and mortality in vaccinated perforin-deficient mice. Immunity 18, 463.
2. Behrens, E. M., Kreiger, P. A., Cherian, S., and Cron, R. Q. (2006). Interleukin 1 receptor antagonist to treat cytophagic histiocytic panniculitis with secondary hemophagocytic lymphohistiocytosis. J. Rheumatol. 33, 2081.
3. Bukowski, J. F., Woda, B. A., Habu, S., Okamura, K., and Welsh, R. M. (1983). Natural killer cell depletion enhances virus synthesis and virus-induced hepatitis in vivo. J. Immunol. 131, 1531.
4. Bukowski, J. F., Woda, B. A., and Welsh, R. M. (1984). Pathogenesis of murinecytomegalovirus infectionin natural killer cell-depleted mice. J. Virol. 52, 119.
5. Chen, J. H., Fleming, M. D., Pinkus, G. S., Pinkus, J. L., Nichols, K. E., Mo, J.Q., and Perez-Atayde, A. R. (2010). Pathology of the liver in familial hemophagocytic lymphohistiocytosis. Am. J. Surg. Pathol. 34, 852.
6. Clementi, R., Emmi, L., Maccario, R., Liotta, F., Moretta, L., Danesino, C., and Arico, M. (2002). Adult onset and atypical presentation of hemophagocytic lymphohistiocytosis in siblings carrying PRF1 mutations. Blood 100, 2266.
7. Crozat, K., Hoebe, K., Ugolini, S., Hong, N. A., Janssen, E., Rutschmann, S., Mudd, S., Sovath, S., Vivier, E., and Beutler, B. (2007) Jinx, an MCMV susceptibility phenotype caused by disruption of Unc13d: a mouse model of type 3 familial hemophagocytic lymphohistiocytosis. J. Exp. Med. 204, 853.
8. Dao, T., Mehal, W., and Crispe, I. N. (1998). IL-18 augments perforin-dependent cytotoxicity of liver NK-T cells. J. Immunol. 161, 2217.
9. Dinarello, C. A. (2007). Interleukin18 and the pathogenesis of inflammatory diseases. Semin. Nephrol. 27, 98.
10. Dinarello, C. A., and Kaplanski, G. (2005). Interleukin-18 treatment options for inflammatory diseases. Expert Rev. Clin. Immunol. 1, 619.
11. Finotto, S., Siebler, J., Hausding, M., Schipp, M., Wirtz, S., Klein, S., Protschka, M., Doganci, A., Lehr, H. A., Trautwein, C., Khosravi-Far, R., Strand, D., Lohse, A., Galle, P. R., Blessing, M., and Neurath, M. F. (2004). Severe hepatic injury in interleukin 18 (IL-18) transgenic mice: a key role for IL-18 in regulating hepatocyte apoptosis in vivo. Gut 53, 392.
12. Grom, A. A. (2004). Natural killer cell dysfunction: a common pathway in systemic-onset juvenile rheumatoid arthritis, macrophage activation syndrome, and hemophagocytic lymphohistiocytosis? Arthritis Rheum. 50, 689.
13. Hasegawa, D., Kojima, S., Tatsumi, E., Hayakawa,A.,Kosaka,Y.,Nakamura, H., Sako, M., Osugi, Y., Nagata, S.,and Sano, K. (1998). Elevation of the serum Fas ligand in patients with hemophagocytic syndrome and Diamond-Blackfan anemia. Blood 91, 2793.
14. Henter, J. I., Elinder, G., Soder, O., Hansson, M., Andersson, B., and Andersson, U. (1991). Hypercytokinemia in familial hemophagocytic lymphohistiocytosis. Blood 78, 2918.
15. Henter, J. I., Horne,A.,Arico, M., Egeler, R. M., Filipovich, A. H., Imashuku, S.,Ladisch,S.,McClain,K.,Webb,D., Winiarski, J., and Janka, G. (2007). HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr. Blood Cancer 48, 124.
16. Hurgin, V., Novick, D., and Rubinstein, M. (2002). The promoter of IL-18 binding protein: activation by an IFN-gamma-induced complex of IFN regulatory factor 1 and CCAAT/enhancer binding protein beta. Proc. Natl. Acad. Sci. U.S.A 99, 16957.
17. Janka, G. E. (2007). Hemophagocytic syndromes. Blood Rev. 21, 245.
18. Janka, G., Imashuku, S., Elinder, G., Schneider, M., and Henter, J. I. (1998). Infectionand malignancyassociated hemophagocytic syndromes. Secondary hemophagocytic lymphohistiocytosis. Hematol. Oncol. Clin. North. Am. 12, 435.
19. Jordan, M. B., Hildeman, D., Kappler, J., and Marrack, P. (2004). An animal model of hemophagocytic lympho-histiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder. Blood 104, 735.
20. Kägi, D., Lederman, B., Bürki, K., Seller, P., Odermatt, B., Olsen, K. J., Podack, E. R., Zinkernagel, R. M., and Hengartner,H. (1994). Cytotox-icity mediated by T cells and nat-ural killer cells is greatly impaired in perforin-deficient mice. Nature 369, 31.
21. Lambotte, O., Khellaf, M., Harmouche, H.,Bader-Meunier,B.,Manceron,V., Goujard, C., Amoura, Z., Godeau, B., Piette, J. C., and Delfraissy, J. F. (2006). Characteristics and long-term outcome of 15 episodes of systemic lupus erythematosus-associated hemophagocytic syn-drome. Medicine (Baltimore) 85, 169.
22. Mazodier, K., Marin, V., Novick, D., Farnarier, C., Robitail, S., Schleinitz, N., Veit, V., Paul, P., Rubinstein, M., Dinarello, C. A., Harle, J. R., and Kaplanski, G. (2005). Severe imbal-ance of IL-18/IL-18BP in patients with secondary hemophagocytic syndrome. Blood 106, 3483.
23. Nold-Petry, C. A., Lehrnbecher, T., Jarisch, A., Schwabe, D., Pfeilschifter, J. M., Muhl, H., and Nold, M. F. (2010). Failure of interferon gamma to induce the anti-inflammatory interleukin 18 binding protein in familial hemo-phagocytosis PLoS ONE doi:10.1371/journal.pone.0008663 5, e8663
24. Novick, D., Kim, S.-H., Fantuzzi, G., Reznikov, L. L., Dinarello, C. A., and Rubistein, M. (1999). Interleukin-18 binding protein: a novel modula-tor of the Th1 cytokine response. Immunity 10, 127.
25. Olin, R. L., Nichols, K. E., Naghashpour, M.,Wasik,M.,Shelly,B.,Stadtmauer, E. A.,andVogl,D. T. (2008). Success-ful use of the anti-CD25 antibody daclizumab in an adult patient with hemophagocytic lymphohistiocyto-sis. Am. J. Hematol. 83, 747.
26. Orange,J. S.,and Biron,C.A. (1996).An absolute and restricted requirement for IL-12 in natural killer cell IFN-gamma production and antiviral defense. Studies of natural killer and T cell responses in contrasting viral infections. J. Immunol. 156, 1138.
27. Osaki, T., Peron, J. M., Cai, Q., Oka-mura, H., Robbins, P. D., Kuri-moto, M., Lotze, M. T., and Tahara, H. (1998). IFN-gamma-inducing factor/IL-18 administra-tion mediates IFN-gamma-and IL-12-independent antitumor effects. J. Immunol. 160, 1742.
28. Pachlopnik Schmid, J., Cote, M., Menager,M. M.,Burgess,A.,Nehme, N., Menasche, G., Fischer, A., and de Saint Basile, G. (2010). Inher-ited defects in lymphocyte cytotoxic activity. Immunol. Rev. 235, 10.
29. Pachlopnik Schmid, J., Ho, C. H., Chretien, F., Lefebvre, J. M., Pivert, G., Kosco-Vilbois, M., Ferlin, W., Geissmann, F., Fischer, A., and de Saint Basile, G. (2009). Neutralization of IFN gamma defeats haemophago-cytosis in LCMV-infected perforin-and Rab27a-deficient mice. EMBO Mol. Med. 1, 112.
30. Pachlopnik Schmid, J., Ho, C. H., Diana, J., Pivert, G., Lehuen, A., Geissmann, F., Fischer, A., and de Saint Basile, G. (2008). A Griscelli syndrome type 2 murine model of hemophagocytic lymphohistiocytosis (HLH). Eur. J. Immunol. 38, 3219.
31. Paulukat, J., Bosmann, M., Nold, M., Garkisch, S., Kampfer, H., Frank, S., Raedle, J., Zeuzem, S., Pfeilschifter, J., and Muhl, H. (2001). Expression and release of IL-18 binding pro-tein in response to IFN-gamma. J. Immunol. 167, 7038.
32. Prahalad, S., Bove, K. E., Dickens, D., Lovell, D. J., and Grom, A. A. (2001). Etanercept in the treatment of macrophage activation syndrome. J. Rheumatol. 28, 2120.
33. Ravelli, A. (2002). Macrophage activation syndrome. Curr. Opin. Rheumatol. 14, 548.
34. Reznikov, L. L., Kim, S. H., Zhou, L., Bufler, P., Goncharov, I., Tsang, M., and Dinarello, C. A. (2002). The combination of soluble IL-18Ralpha and IL-18Rbeta chains inhibits IL-18-induced IFN-gamma. J. Interferon Cytokine Res. 22, 593.
35. Riedemann, N. C., Guo, R. F., and Ward, P. A. (2003). The enigma of sepsis. J. Clin. Invest. 112, 460.
36. Robbins, S. H., Bessou, G., Cornil-lon, A., Zucchini, N., Rupp, B., Ruzsics, Z., Sacher, T., Tomasello, E., Vivier, E., Koszinowski, U. H., and Dalod, M. (2007). Natural killer cells promote early CD8 T cell responses against cytomegalovirus PLoS Pathog doi:10.1371/journal.ppat.0030123 3, e123
37. Rouphael, N. G., Talati, N. J., Vaughan, C., Cunningham, K., Moreira, R., and Gould, C. (2007). Infections associated with haemophagocytic syndrome. Lancet. Infect. Dis. 7, 814.
38. Sathiyamoorthy, S., Shad, A., and Ozdemirli, M. (2011). Acute promyelocytic leukemia following chemotherapy for EBV-associated hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 56, 850.
39. Stepp, S. E., Dufourcq-Lagelouse, R., Le Deist, F., Bhawan, S., Certain, S., Mathew, P. A., Henter, J. I., Bennett, M., Fischer, A., de Saint Basile,G.,and Kumar,V. (1999). Per-forin gene defects in familial hemo-phagocytic lymphohistiocytosis. Sci-ence 286, 1957.
40. Tak, P. P., Bacchi, M., and Bertolino, M. (2006). Pharmacokinetics of IL-18 binding protein in healthy volunteers and subjects with rheumatoid arthritis or plaque psoriasis. Eur. J. Drug Metab. Pharmacokinet. 31,109
41. Takada, H., Ohga, S., Mizuno, Y., Sum-inoe, A., Matsuzaki, A., Ihara, K., Kinukawa, N., Ohshima, K., Kohno, K., Kurimoto, M., and Hara, T. (1999). Oversecretion of IL-18 in haemophagocytic lymphohistiocytosis: a novel marker of disease activity. Br. J. Haematol. 106, 182.
42. To, K. K., Hung, I. F., Li, I. W., Lee, K. L., Koo, C. K., Yan, W. W., Liu, R., Ho, K. Y., Chu, K. H., Watt, C. L., Luk, W. K., Lai, K. Y., Chow, F. L., Mok, T., Buckley, T., Chan, J. F., Wong, S. S., Zheng, B., Chen, H., Lau, C. C., Tse, H., Cheng, V. C., Chan, K. H., and Yuen,K.Y. (2010). Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1 N1 2009 influenza virus infection. Clin.Infect.Dis.50,850.
43. Tsutsui, H., Kayagaki, N., Kuida, K., Nakano, H., Hayashi, N., Takeda, K., Matsui, K., Kashiwamura, S., Hada, T., Akira, S., Yagita, H., Okamura, H., and Nakanishi, K. (1999). Caspase-1-independent, Fas/Fas ligand-mediated IL-18 secretion from macrophages causes acute liver injury in mice. Immunity 11, 359.
44. Tsutsui, H., Matsui, K., Okamura, H., and Nakanishi, K. (2000). Patho-physiological roles of interleukin-18 in inflammatory liver diseases. Immunol. Rev. 174, 192.
45. Van Dommelen, S. L., Sumaria, N., Schreiber, R. D., Scalzo,A. A., Smyth, M. J., and Degli-Esposti, M. A. (2006). Perforin and granzymes have distinct roles in defensive immunity and immunopathology. Immunity 25, 835.
46. Walsh, C. M., Matloubian, M., Liu, C. C., Ueda, R., Kurahara, C. G., Christensen, J. L., Huang, M. T., Young, J. D., Ahmed, R., and Clark, W. R. (1994). Immune function in mice lacking the perforin gene. Proc. Natl. Acad. Sci. U.S.A. 91, 10854.
47. Walzer,T.,Bléry,M.,Chaix,J.,Fuseri,N., Chasson, L., Robbins, S. H., Jaeger,S., André, P., Gauthier, L., Daniel, L., Chemin, K., Morel, Y., Dalod, M., Imbert, J., Pierres, M., Moretta, A., Romagné, F., and Vivier, E. (2007). Identification, activation, and selective in vivo ablation of mouse NK cells via NKp46. Proc. Natl. Acad. Sci. U.S.A 104, 3384.
48. Wigginton, J. M., Lee, J. K., Wiltrout, T. A., Alvord, W. G., Hixon, J. A., Sub-leski, J., Back, T. C., and Wiltrout, R. H. (2002). Synergistic engagement of an ineffective endogenous antitumor immune response and induction of IFN-gamma and Fas-ligand-dependent tumor eradication by combined administration of IL-18 and IL-2. J. Immunol. 169, 4467.
49. Yuen, K. Y., Chan, P. K., Peiris, M., Tsang, D. N., Que, T. L., Short-ridge, K. F., Cheung, P. T., To, W. K., Ho, E. T., Sung, R., and Cheng, A. F. (1998). Clinical features and rapid viral diagnosis of human dis-ease associated with avian influenza A H5N1 virus. Lancet 351, 467.
50. Zhang, K., Biroschak, J., Glass, D. N., Thompson, S. D., Finkel, T., Passo, M. H., Binstadt, B. A., Fil-Ipovich, A., and Grom, A. A. (2008). Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis is associated with Munc 13-4 polymorphisms. Arthritis Rheum. 58, 2892